Carlsmed (CARL) Free Cash Flow (2024 - 2026)

Carlsmed (CARL) has reported Free Cash Flow for 3 consecutive years, with -$8.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow fell 9.44% year-over-year to -$8.0 million; the trailing twelve-month figure through Jun 2026 stood at -$35.2 million (down 28.0% YoY), and the FY2025 full-year result was -$29.7 million, down 15.78% from the prior year.
• Free Cash Flow grew to -$8.0 million in Q2 2026 per CARL's latest filing, from -$13.1 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$4.3 million in Q4 2024 and bottomed at -$13.1 million in Q1 2026.
• Historically, Free Cash Flow has averaged -$7.8 million across 3 years, with a median of -$7.8 million in 2024.
• The widest YoY moves for Free Cash Flow: up 9.44% in 2026, down 58.05% in 2026.
• Over 3 years, Free Cash Flow stood at -$4.3 million in 2024, then declined by 28.21% to -$5.5 million in 2025, then slumped by 46.08% to -$8.0 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$8.0 million, -$13.1 million, and -$5.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.